OFFICIAL-SOURCE RECALL · CANADA
pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ Recall: The affected lot may contain
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CountryCanadaPublishedAugust 12, 2026Last updatedAugust 12, 2026Official source last checkedAugust 13, 2026 at 4:09 PM UTC
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.
- Manufacturer
- See official notice
- Lot number
- may, may-contain-pms-irbesarta, affecte-peut-contenir-com, Number
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
The affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.
Hazard
The affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.
Official recall notice
pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.
Agency: Health Canada
Official publication date: August 12, 2026
Read the official CANADA_HEALTH recall notice →Scan products you own
Scan products you own once and let RecallGuard monitor future official recalls.
Scan & Monitor Products